Oncotarget

Research Papers:

Deep analysis of acquired resistance to FGFR1 inhibitor identifies MET and AKT activation and an expansion of AKT1 mutant cells

Pol Gimenez-Xavier, Eva Pros, Ana Aza, Sebastian Moran, Raul Tonda, Anna Esteve-Codina, Marc Dabad and Montse Sanchez-Cespedes _

PDF  |  HTML  |  Supplementary Files  |  How to cite  |  Order a Reprint

Oncotarget. 2018; 9:31549-31558. https://doi.org/10.18632/oncotarget.25862

Metrics: PDF 677 views  |   HTML 1924 views  |   ?  


Abstract

Pol Gimenez-Xavier1,*, Eva Pros1,*, Ana Aza1, Sebastian Moran2, Raul Tonda3,4, Anna Esteve-Codina3,4, Marc Dabad3,4 and Montse Sanchez-Cespedes1

1Genes and Cancer Group, Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute-IDIBELL, Hospitalet de Llobregat, Barcelona, Spain

2Cancer Epigenetics Group, Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute-IDIBELL, Hospitalet de Llobregat, Barcelona, Spain

3CNAG-CRG, Centre for Genomic Regulation (CRG) and Institute of Science and Technology (BIST), Barcelona, Spain

4Universitat Pompeu Fabra (UPF), Barcelona, Spain

*These authors contributed equally to this work

Correspondence to:

Montse Sanchez-Cespedes, email: mscespedes@idibell.cat

Keywords: lung cancer; FGFR1; acquired resistance; tyrosine kinase inhibitor; cell lines

Received: May 25, 2018     Accepted: July 16, 2018     Published: July 31, 2018

ABSTRACT

The development of acquired resistance (AR) to tyrosine kinase inhibitors (TKIs) of FGFR1 activation is currently not well understood. To gain a deeper insight into this matter in lung cancer, we used the FGFR1-amplified DMS114 cell line and generated multiple clones with AR to an FGFR1-TKI. We molecularly scrutinized the resistant cells, using whole-exome sequencing, RNA sequencing and global DNA methylation analysis. Our results show a de novo activation of AKT and ERK, and a reactivation of mTOR. Furthermore, the resistant cells exhibited strong upregulation and activation of MET, indicating crosstalk between the FGFR1 and MET axes. The resistant cells also underwent a global decrease in promoter hypermethylation of the CpG islands. Finally, we observed clonal expansion of a pre-existing change in AKT1, leading to S266L substitution, within the kinase domain of AKT. Our results demonstrate that AR to FGFR1-TKI involves deep molecular changes that promote the activation of MET and AKT, coupled with common gene expression and DNA methylation profiles. The expansion of a substitution at AKT1 was the only shared genetic change, and this may have contributed to the AR.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 25862